Inactive

2 Rubidium Generator and Supplies - Combined Synopsis/Solicitation This is a Request for Quote (RFQ) combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR S... 2 Rubidium Generator and Supplies - Combined Synopsis/Solicitation This is a Request for Quote (RFQ) combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6 - Streamlined Procedures for Evaluation and Solicitation for Commercial Items, in conjunction with FAR -- Part 13 Simplified Acquisition Procedures and FAR Part 13.5; and supplemented with additional information included in this notice. Solicitation 36C26221Q0309 is issued as a Request for Quote (RFQ) and constitutes the only solicitation. The Government intends to award a single Firm-Fixed Price (FFP) award contract. This solicitation document and incorporated provisions and clauses are those in effect through the Federal Acquisition Circular 2020-09, dated October 26, 2020. This solicitation intends to award a contract through full and open competition to a business associated with NAICS Code 325412 with the Small Business Administration s (SBA) size standard of 1250 Employees. The Department of Veterans Affairs (VA) seeks to make a procurement for Pharmaceutical Product, Rubidium Generator and Supplies. Rubidium (RB-18) Generator is a closed system used to produce rubidium RB-82 chloride injection for intravenous administration. Rubidium RB-82 chloride injection is indicated for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease. This process shows how much blood is getting to the heart muscle when patients are resting or exercising (stressed). Rubidium RB 82 belongs to the group of medications called radiopharmaceuticals (radioactive agents). The PET/CT method can obtain calcium scores to assess a patient's long-term prognosis. The radiopharmaceutical Rubidium-82 generator, 18" x 12" is a closed system used to produce rubidium RbB82 chloride injection for Intravenous administration. The radiation of the generator is shielded in a 30" x 30" x 22 generator cart. The generator and the generator cart are connected. This solicitation is seeking the following systems and components as brand name or equal to products: Please see attached Statement of Work. Line Items Requested: ITEM NUMBER DESCRIPTION OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT 0002 7.00 EA Ruby-Fill Rubidium RB-82 Generator 7-week generator cycle/delivery 0003 12.00 EA Ruby Rubidium Elution System Lease/per month LOCAL STOCK NUMBER: 720000000230 0004 12.00 EA Ruby IV line (box of 100 lines) LOCAL STOCK NUMBER: 80000000532 0005 1.00 EA Ruby- Connectors (set of 2 connectors) LOCAL STOCK NUMBER: 30000001360 0006 1.00 EA Ruby Printer Paper (block of 250 labels) LOCAL STOCK NUMBER: 710000001561 0007 1.00 EA Ruby Luer Caps (Sterile) (box of 1000 caps) LOCAL STOCK NUMBER: 80000000501 0008 1.00 EA Ruby Glass QC vials (box of 10 vials) LOCAL STOCK NUMBER: 80000000510 0009 1.00 EA Ruby Set-USA LOCAL STOCK NUMBER: 80000000530 0010 1.00 EA Ruby Saline Line (box of 50 lines) LOCAL STOCK NUMBER: 80000000531 0011 1.00 EA Microclave Clear Connectors (box of 100) LOCAL STOCK NUMBER: 8000000870 012 Ruby Fill 1.00 EA Elution system from KDI to customer - 1 time 014 Ruby Fill 1.00 EA Accessories to customer for 7 weeks generator cycle                         015 Ruby Fill Ruby Generator for 7 weeks generator cycle Offeror quotations must demonstrate meeting the salient physical, functional, or performance characteristic specified in this solicitation, otherwise it will be considered non-responsive. The technical specifications for this requirement are listed for Brand Name or Equal per FAR 52.211-6. The information identified above is intended to be descriptive, not restrictive and to indicate the quality that will be satisfactory. The interested parties bear full responsibility to ensure their submission demonstrates to the government that they can provide the brand name or equal to supplies being requested. For equal to product, submission must demonstrate functionalities and capabilities equal to that of the brand name. Place of Performance: VA Los Angeles Healthcare System, 11301 Wilshire Blvd, Los Angeles, CA 90073. Period of Performance: Base Year: 03/01/2021 to 02/28/2022 Option Year 1: 03/01/2022 to 02/28/2023 Option Year 2: 03/01/2023 to 02/28/2024 The period of performance will start shortly after award for a One (1) Year Base Period with the Government having the option to exercise (2) two and (1) one-year renewal periods in conjunction with 52.217-9. The provisions 52.212-1, Instructions to Offerors Commercial and 52.212-2, Evaluation Commercial Items are applicable to this acquisition. Furthermore, Provision 52.212-2 is utilizing the lowest price on an Acceptable/Unacceptable evaluation process. Submitting Quote: Offeror(s) shall submit their quote on company letterhead and shall include the completed pricing forms, along with name, address, telephone number of the offeror, firm s DUNS#, total price and a completed copy of FAR Clause 52.212-3 Offerors Representations and Certifications - Commercial Items or a copy of offeror s annual offeror representations and certifications (ORCA) document from www.sam.gov as required by FAR Clause 52.212-3 Offerors Representations and Certifications - Commercial Items. Submit all question(s) to Anette Doan at Anette.doan@va.gov no later than February 11, 2021, 12:00 PM Pacific Daylight Time (PDT). Ensure to reference solicitation 36C26221Q0309 within subject line of the email. Quotes must be received via email by February 15, 2021 by 12:00 PM PDT. Email your quote to Anette Doan at Anette.doan@va.gov. Ensure to reference solicitation 36C26221Q0309 within subject line of the email. Quote(s)/offer(s) received after the prescribed deadline, shall be considered non-responsive and will not be considered for award. CONTRACT CLAUSES AND PROVISIONS Please see Rubidium 36C26221Q0309_1 for full disclosure.